Dianthus Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Disc Medicine Q1 2026 Earnings Narrowed Loss Beats Estimates as Biotech Advances Hematology Pipeline Ocugen Inc OCGN Q1 2026 Earnings Wider Loss Misses Estimate as PreRevenue Biotech Focuses on Pipeline SYK Q1 2026 Earnings EPS Misses Expectations as Stock Edges Lower MicroVision Q1 2026 Earnings EPS Misses Estimates Stock Rises Despite Revenue Absence Ralliant Corporation RAL Q1 2026 Earnings EPS Beats Estimates by 1531